By Jacob Wolinsky. Originally published at ValueWalk.
April 27 — Bill Ackman, Pershing Square Capital Management’s chief executive officer, speaks at a Senate hearing on Valeant and drug pricing. Pershing Square has investments in Valeant.
The post Bill Ackman Talks To Congress About Valeant appeared first on ValueWalk.
Sign up for ValueWalk’s free newsletter here.